Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

81 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Population Pharmacokinetics of the Antituberculosis Agent Pretomanid.
Salinger DH, Subramoney V, Everitt D, Nedelman JR. Salinger DH, et al. Among authors: everitt d. Antimicrob Agents Chemother. 2019 Sep 23;63(10):e00907-19. doi: 10.1128/AAC.00907-19. Print 2019 Oct. Antimicrob Agents Chemother. 2019. PMID: 31405856 Free PMC article.
Treatment of Highly Drug-Resistant Pulmonary Tuberculosis.
Conradie F, Diacon AH, Ngubane N, Howell P, Everitt D, Crook AM, Mendel CM, Egizi E, Moreira J, Timm J, McHugh TD, Wills GH, Bateson A, Hunt R, Van Niekerk C, Li M, Olugbosi M, Spigelman M; Nix-TB Trial Team. Conradie F, et al. Among authors: everitt d. N Engl J Med. 2020 Mar 5;382(10):893-902. doi: 10.1056/NEJMoa1901814. N Engl J Med. 2020. PMID: 32130813 Free PMC article. Clinical Trial.
Bedaquiline-Pretomanid-Linezolid Regimens for Drug-Resistant Tuberculosis.
Conradie F, Bagdasaryan TR, Borisov S, Howell P, Mikiashvili L, Ngubane N, Samoilova A, Skornykova S, Tudor E, Variava E, Yablonskiy P, Everitt D, Wills GH, Sun E, Olugbosi M, Egizi E, Li M, Holsta A, Timm J, Bateson A, Crook AM, Fabiane SM, Hunt R, McHugh TD, Tweed CD, Foraida S, Mendel CM, Spigelman M; ZeNix Trial Team. Conradie F, et al. Among authors: everitt d. N Engl J Med. 2022 Sep 1;387(9):810-823. doi: 10.1056/NEJMoa2119430. N Engl J Med. 2022. PMID: 36053506 Free PMC article. Clinical Trial.
An Exposure-Response Perspective on the Clinical Dose of Pretomanid.
Nedelman JR, Salinger DH, Subramoney V, Woolson R, Wade K, Li M, Everitt D, Mendel CM, Spigelman M. Nedelman JR, et al. Among authors: everitt d. Antimicrob Agents Chemother. 2020 Dec 16;65(1):e01121-20. doi: 10.1128/AAC.01121-20. Print 2020 Dec 16. Antimicrob Agents Chemother. 2020. PMID: 33077660 Free PMC article.
Clofazimine pharmacokinetics in patients with TB: dosing implications.
Abdelwahab MT, Wasserman S, Brust JCM, Gandhi NR, Meintjes G, Everitt D, Diacon A, Dawson R, Wiesner L, Svensson EM, Maartens G, Denti P. Abdelwahab MT, et al. Among authors: everitt d. J Antimicrob Chemother. 2020 Nov 1;75(11):3269-3277. doi: 10.1093/jac/dkaa310. J Antimicrob Chemother. 2020. PMID: 32747933 Free PMC article.
Safety and pharmacokinetics of an intramuscular monoclonal antibody (SB 209763) against respiratory syncytial virus (RSV) in infants and young children at risk for severe RSV disease.
Meissner HC, Groothuis JR, Rodriguez WJ, Welliver RC, Hogg G, Gray PH, Loh R, Simoes EA, Sly P, Miller AK, Nichols AI, Jorkasky DK, Everitt DE, Thompson KA. Meissner HC, et al. Among authors: everitt de. Antimicrob Agents Chemother. 1999 May;43(5):1183-8. doi: 10.1128/AAC.43.5.1183. Antimicrob Agents Chemother. 1999. PMID: 10223933 Free PMC article. Clinical Trial.
81 results